CBT-I for insomnia in older African American adults
Official title: Cognitive Behavioral Therapy for Insomnia in Older African American Adults
Run by Rutgers, The State University of New Jersey · NCT06791356 · Data updated 2026-11-12
This project will try an eight-session online CBT-I program to see if it helps older African American adults who have chronic insomnia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (Newark, New Jersey) |
| Status | Recruiting |
| Started | June 2, 2025 |
| Main results expected | June 2026 |
| Study ends | June 2027 |
| Registry record updated | February 20, 2026 |
| Trial ID | NCT06791356 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking African American adults age 60+ enrolled in the Pathways to Healthy Aging study with at least three months of insomnia, PSQI component scores >2 as specified, and MoCA scores of 20–26 who can attend Rutgers for assessments and join eight Zoom sessions.
✕Probably not a fit
People taking certain regular sedative or sleep-altering medications, those with MoCA scores below 20, those not enrolled in the Pathways cohort, or those unable to use Zoom or travel to Rutgers for assessments are unlikely to be eligible or benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot interventional study will test the feasibility and preliminary effects of cognitive-behavioral therapy for insomnia (CBT-I) delivered in eight sessions via Zoom, compared with sleep hygiene education, among older African American participants drawn from the Pathways to Healthy Aging cohort. Participants must be age 60 or older, self-identify as African American or Black, have chronic insomnia for at least three months, meet brief sleep disturbance thresholds on the PSQI-derived components, and have a MoCA score between 20 and 26. The protocol includes pre- and post-intervention assessment visits at Rutgers University (Newark, NJ) and remote therapy sessions, with medication and cognitive-screening exclusions to reduce confounding. As a feasibility pilot, the study will generate preliminary outcome data to inform larger trials focused on this underrepresented population.
Why it matters
Potential benefit: If successful, the program could improve sleep quality and reduce insomnia symptoms long-term without relying on sleep medications.
How similar studies have gone: CBT-I has shown consistent benefits for adults and older adults with insomnia in prior studies, but targeted evidence in older African American populations is limited, making this application relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Reading level 6th grade or better and can speak and understand English well. * Self-identify as African American or Black. * Ages 60 and over. * Score of \>2 in PSQI sleep duration, sleep disturbance, or overall sleep quality calculated components. * Participating in the "Pathways to Healthy Aging in African Americans" study. * Has established chronic insomnia issues for at least three months. * Subjects must be willing to participate in 8 sessions of CBT-I via Zoom for the CBT-I group. * Subjects must be willing to come for pre/post assessment visits. * MoCA score of between 20-26. Exclusion Criteria: * Currently taking any of the following medications consistently: Benzodiazepines (ProSom, Restoril, Ativan and Xanax); Z Drugs (eszopiclone (Lunesta), zaleplon (Sonata) and zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist); antidepressants that affect sleep (doxepin, mirtazapine, trazodone); antihistamines (diphenhydramine and doxylamine succinate); barbiturates (methohexital, pentobarbital, primidone, secobarbital). * Diagnosed with any sleep disorder other than insomnia (i.e. obstructive sleep apnea using STOP-BANG, restless leg syndrome, REM sleep behavior disorder, etc.). * Classified as high fall risk. * Primary causes for frequent awakenings are due to a medical condition that is not related to insomnia, such as chronic pain, urinary frequency, upper respiratory infection. * Previous experience with CBT-I.
Where it's running
-
Rutgers University
Newark, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Mark Gluck, PhD — Rutgers University
- Study coordinator: Payton White
- Email: pw352@newark.rutgers.edu
- Phone: (973)-353-6373
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Influenza Vaccine Immunogenicity in Older Adults with Repeated Vaccination
This study tests how different flu vaccines perform in adults 65+ who get yearly vaccines to see if age and repeated vaccination affect the immune response.
-
Seeing the world from home: using virtual reality travel to help lonely older adults
A small pilot study will test whether virtual reality travel experiences can help reduce loneliness in people aged 65 and older who are open to trying VR.
-
eCardiacRehab: a home-based, patient-centered cardiac rehab program
This trial tests a hybrid home-based cardiac rehabilitation program to see if it reduces cardiovascular deaths and ED visits while improving quality of life for adults with CAD after PCI, compared with usual care.
-
Short versus long intermittent hypoxic-hyperoxic training for people with type 2 diabetes, including older adults
This study will see if short (3-day) or longer (10-day) sessions of intermittent low-oxygen/high-oxygen breathing improve blood sugar control in people aged 50–74 with type 2 diabetes.
-
Promoting Walking for Older Adults with Friendly Messages and Step Reminders
This study tests whether friendly affective messages and step-tracking reminders can help adults aged 65–74 walk more, by linking memories of their past selves to their present and future actions.
-
How short power-training sessions affect muscle power and movement in older adults.
This test will try three leg-press power-training sessions with different fatigue levels to see which approach is safest and most helpful for adults aged 65–85.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.